influenza
Conditions
Interventions
test group:REDUNING injection and Phosphate oseltamivir capsules placebo
control group:Phosphate oseltamivir capsules and REDUNING injection placebo
Sponsors
Tianjin University of Traditional Chinese Medcine
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1) patients who are accordance with influenza high fever diagnostic standards; 2) patients who are accordance with the TCM syndrome of toxic heat invading lung; 3) the result of influenza virus antigen detection kit is positive; 4) patients whose temperature under armpit higher than 39.0 degree; 5) patients who are in the 18-25 age bracket; 6) patients whose course of disease is within 24 hours; 7) patients who muse be voluntary to the trail and sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1) severe flu patients who are in accordance with "Influenza diagnosis and treatment guidelines (2011 edition) issued by Office of the Ministry of Health; 2) patients who are accompanied with Chronic respiratory disease, acutely paroxysmal phase of chronically asthmatic bronchitis, pneumonia, pharyngo conjunctivitis, suppurative tonsillitis; 3) patients whose WBC of routine blood test is greater than the upper limit of normal, or N% more than 75%; 4) patients who are accompanied with heart, liver and kidney disease, hematological system disease and metabolic diseases (such as diabetes, Thyroid disease, adrenal diseases) and cancer; 5) immune deficiency disease or use of immunosuppressive drugs or corticosteroids in nearly 3 months; 6) women who will be pregnancy, or gravida, or during lactation; 7) patients who are allergic constitution, As a general rule, these patients are allergic to any two or more types of medication or food; 8) patients who have taken part in any other clinical trails in recent 3 months; 9) people who is a mental patient, or has incapacity of know himself; 10) patients who have used flu vaccine in recent 12 months before took part in this trail; 11) patients who have used any influenza drug before saw a doctor.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Time of temperature to nomal; | — |
Secondary
| Measure | Time frame |
|---|---|
| body temperature return to normal time;Effects of influenza;Effects of TCM symptoms;Effects of single symptom;Disease outcome;The number of antipyretic analgesics; | — |
Countries
China
Contacts
Public ContactSun Zengtao
Outcome results
None listed